Stocks Comparison
Airsculpt Technologies vs Teladoc Health: revenue, profit, margins and growth compared
Airsculpt Technologies brought in $151.8M of revenue in fiscal 2025, Teladoc Health $2.5B in fiscal 2025. Revenue changed by -15.8% at Airsculpt Technologies and -1.5% at Teladoc Health on the year before, so Teladoc Health grew faster. Airsculpt Technologies kept -7.7% of its revenue as net profit, Teladoc Health -7.9%. Free cash flow was $692K at Airsculpt Technologies and $285.5M at Teladoc Health.
Side by side, latest fiscal year
| AIRS | TDOC | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $151.8M | $2.5B |
| Revenue growth | -15.8% | -1.5% |
| Net income | -$11.7M | -$200.3M |
| Net margin | -7.7% | -7.9% |
| Free cash flow | $692K | $285.5M |
| Free cash flow margin | 0.5% | 11.3% |
| Earnings per share (diluted) | -$0.19 | -$1.14 |
| Cash | $8.4M | $781.1M |
| Debt | $56M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $141.3M | $1.1B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #271 of 523 · Health care | #96 of 523 · Health care |
Over the years
Questions about Airsculpt Technologies and Teladoc Health
Which is bigger by revenue, Airsculpt Technologies or Teladoc Health?
Teladoc Health is bigger by revenue: $2.5B in fiscal 2025, against $151.8M for Airsculpt Technologies in fiscal 2025.
Which keeps more of its revenue as profit, Airsculpt Technologies or Teladoc Health?
Airsculpt Technologies had a net margin of -7.7% in fiscal 2025; Teladoc Health had -7.9% in fiscal 2025.
Which grew revenue faster, Airsculpt Technologies or Teladoc Health?
In their latest fiscal years revenue changed by -15.8% at Airsculpt Technologies and -1.5% at Teladoc Health.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.